Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Curry JL et al. – Immunodeficiency–related lymphoproliferative disorders (IR–LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF–alpha antagonists.

Related Articles

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
Annals of Oncology, 11/16/09    Relevance Score: 64%

Cerebral mycosis: 7-year retrospective series in a tertiary center
Neuropathology, 11/03/09    Relevance Score: 64%

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Journal of Clinical Oncology, 10/20/09    Relevance Score: 64%

A practical approach to using methotrexate
Dermatology in Practice, 10/14/09    Relevance Score: 62%

Algorithm of Clinical Protocol Lowering the Risk of Systemic Mycosis Infections in Allografts Recipients
Transplantation Proceedings, 11/11/09    Relevance Score: 43%

Today in Dermatology...keeping you current

Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09

Familial atypical cold urticaria: Description of a new hereditary disease
Journal of Allergy and Clinical Immunology, 11/24/09

Leucoderma after use of a skin-lightening cream containing kojic dipalmitate, liquorice root extract and Mitracarpus scaber extract
Clinical and Experimental Dermatology, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address